-
Make sure you know the measles immune status of your employees and have ready access to the information.
-
The seemingly benign use of a checklist to ensure infection control measures are followed during a clinical procedure erupted in controversy recently when a federal agency questioned whether one such program fell into the category of human research.
-
-
-
Most of us dread the chief complaint of weakness. This nonspecific symptom engenders a differential that ranges from malingering to fatal, from psychiatric to cancer. The finding of demonstrable muscle weakness helps, but then leads to a confusing set of relatively rare diagnoses.
-
-
In this Issue: Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
-
Strategies that include developing close relationships with post-acute providers; meetings to explore options for extended-stay patients; and collaboration between nurse practitioners, hospitalists, and the interdisciplinary care team have helped Catawba Valley Medical Center in Hickory, NC, reduce the number of patients who stay more than 15 days.
-
Deciding whether patients should be in observation or inpatient status always has been a challenge for hospitals and now that the Centers for Medicare & Medicaid Services (CMS) has embarked on a nationwide program to audit for overpayment, placing patients in the correct status is more critical than ever.
